Home >> Signaling Pathways >> Ubiquitination/ Proteasome

Ubiquitination/ Proteasome

Products for  Ubiquitination/ Proteasome

  1. Cat.No. Product Name Information
  2. GN10103 Neferine Neferine  Chemical Structure
  3. GC13793 NH125 Selective eEF-2 kinase inhibitor NH125  Chemical Structure
  4. GC65072 Niacin-13C6 Niacin-13C6  Chemical Structure
  5. GC10678 Nicardipine HCl Nicardipine HCl (YC-93) is a calcium channel blocker with an IC50 of 1 μM for blocking cardiac calcium channels. Nicardipine HCl  Chemical Structure
  6. GC44400 Niclosamide (ethanolamine salt) Niclosamide (BAY2353) olamine is an orally active antihelminthic agent used in parasitic infection research. Niclosamide (ethanolamine salt)  Chemical Structure
  7. GC36736 Nicodicosapent Nicodicosapent is a fatty acid niacin conjugate that is also an inhibitor of the sterol regulatory element binding protein (SREBP), a key regulator of cholesterol metabolism proteins such as PCSK9, HMG-CoA reductase, ATP citrate lyase, and NPC1L1. Nicodicosapent  Chemical Structure
  8. GC13206 Nicotinic Acid Nicotinic Acid (Vitamin B3) is an orally active water-soluble B3 vitamin that is an essential nutrient for humans. Nicotinic Acid  Chemical Structure
  9. GC34686 Nidufexor

    An FXR partial agonist

    Nidufexor  Chemical Structure
  10. GC15024 Nifedipine L-type calcium channel blocker Nifedipine  Chemical Structure
  11. GC14237 Nilotinib monohydrochloride monohydrate A Bcr-Abl inhibitor Nilotinib monohydrochloride monohydrate  Chemical Structure
  12. GC16587 Nimodipine Calcium Channel inhibitor & Autophagy activator Nimodipine  Chemical Structure
  13. GC11618 Nitazoxanide Antiprotozoal agent Nitazoxanide  Chemical Structure
  14. GC16999 Nitrendipine Calcium channel blocker Nitrendipine  Chemical Structure
  15. GC34009 Nitroprusside disodium dihydrate (Sodium nitroprusside dihydrate) Nitroprusside disodium dehydrate (Sodium nitroprusside dihydrate) is a vasodilator that available for the research of acute hypertension, heart failure. Nitroprusside disodium dihydrate (Sodium nitroprusside dihydrate)  Chemical Structure
  16. GC11365 Nitroxoline antibacterial agent Nitroxoline  Chemical Structure
  17. GC39411 NL-1 NL-1 is a mitoNEET inhibitor with antileukemic effect. NL-1 inhibits REH and REH/Ara-C cells growth with IC50s of 47.35 ?M and 56.26 ?M, respectively. NL-1-mediated death in leukemic cells requires the activation of the autophagic pathway. NL-1  Chemical Structure
  18. GC32874 NMS-859 NMS-859 is a potent, covalent VCP (p97) inhibitor, with IC50s of 0.37 and 0.36 μM for wild-type VCP in the presence of 60 μM and 1 mM ATP in cells, respectively. NMS-859  Chemical Structure
  19. GC17250 NMS-873 VCP/p97 inhibitor,selective and allosteric NMS-873  Chemical Structure
  20. GN10325 Nobiletin Nobiletin  Chemical Structure
  21. GC14075 Nocodazole A tubulin production inhibitor,anti-neoplastic agent Nocodazole  Chemical Structure
  22. GC50113 Noradrenaline bitartrate Norepinephrine (Levarterenol; L-Noradrenaline) tartrate is a potent adrenergic receptor (AR) agonist. Noradrenaline bitartrate  Chemical Structure
  23. GC10976 Noradrenaline bitartrate monohydrate Norepinephrine (Levarterenol; L-Noradrenaline) bitartrate monohydrate is a potent adrenergic receptor (AR) agonist. Noradrenaline bitartrate monohydrate  Chemical Structure
  24. GC18089 Nordihydroguaiaretic acid A non-selective LO inhibitor Nordihydroguaiaretic acid  Chemical Structure
  25. GC30744 Norepinephrine (Adrenor) Norepinephrine (Adrenor) (Levarterenol; L-Noradrenaline) is a potent adrenergic receptor (AR) agonist. Norepinephrine (Adrenor)  Chemical Structure
  26. GC36758 Norepinephrine hydrochloride Norepinephrine (Levarterenol; L-Noradrenaline) hydrochloride is a potent adrenergic receptor (AR) agonist. Norepinephrine hydrochloride  Chemical Structure
  27. GC64076 Nortriptyline Nortriptyline (Desmethylamitriptyline), the main active metabolite of Amitriptyline, is a tricyclic antidepressant used to relieve the symptoms of depression. Nortriptyline  Chemical Structure
  28. GC11989 Nortriptyline (hydrochloride) norepinephrine and serotonin transporters blocker Nortriptyline (hydrochloride)  Chemical Structure
  29. GC32821 Noscapine ((S,R)-Noscapine) Noscapine ((S,R)-Noscapine)  Chemical Structure
  30. GC39023 Notoginsenoside Fc Notoginsenoside Fc, a protopanaxadiol- (PPD-) type saponin isolated from the leaves of Panax notoginseng, effectively counteracts platelet aggregation. Notoginsenoside Fc  Chemical Structure
  31. GC16486 Novobiocin Sodium

    aminocoumarin antibiotic

    Novobiocin Sodium  Chemical Structure
  32. GC12424 NS 1643 hERG KV11.1 channel activator NS 1643  Chemical Structure
  33. GC44464 NSC 109555 An inhibitor of Chk2 NSC 109555  Chemical Structure
  34. GC34924 NSC 185058 An inhibitor of ATG4B NSC 185058  Chemical Structure
  35. GC15017 NSC 624206 Ubiquitin-activating enzyme (E1) inhibitor NSC 624206  Chemical Structure
  36. GC12475 NSC 632839 hydrochloride A deubiquitylase and deSUMOylase inhibitor NSC 632839 hydrochloride  Chemical Structure
  37. GC11932 NSC697923 Inhibitor of E2 complex Ubc13-Uev1A,cell permeable and selective NSC697923  Chemical Structure
  38. GC10470 Nutlin-3a chiral An inhibitor of the p53-Mdm2 interaction Nutlin-3a chiral  Chemical Structure
  39. GC12963 NVP-AEW541 IGF-IR inhibitor, novel, potent and selective NVP-AEW541  Chemical Structure
  40. GC16145 NVP-BGT226 BGT226 (NVP-NVP-BGT226) is a PI3K (with IC50s of 4 nM, 63 nM and 38 nM for PI3Kα, PI3Kβ and PI3Kγ) /mTOR dual inhibitor which displays potent growth-inhibitory activity against human head and neck cancer cells. NVP-BGT226  Chemical Structure
  41. GC11569 Obatoclax mesylate (GX15-070) An antagonist of pro-survival Bcl-2 proteins Obatoclax mesylate (GX15-070)  Chemical Structure
  42. GC14158 Obeticholic Acid A FXR agonist with anticholeretic activity Obeticholic Acid  Chemical Structure
  43. GC64358 Olacaftor Olacaftor (VX-440) is a cystic fibrosis transmembrane conductance regulator (CFTR) modulator extracted from patent US9782408. Olacaftor  Chemical Structure
  44. GC12495 Olanzapine Olanzapine (LY170053) is a selective, orally active monoaminergic antagonist with high affinity binding to serotonin H1, 5HT2A/2C, 5HT3, 5HT6 (Ki=7, 4, 11, 57, and 5 nM, respectively), dopamine D1-4 (Ki=11 to 31 nM), muscarinic M1-5 (Ki=1.9-25 nM), and adrenergic α1 receptor (Ki=19 nM). Olanzapine  Chemical Structure
  45. GC61809 Olanzapine D3 Olanzapine D3 (LY170053-d3) is the deuterium labeled Olanzapine. Olanzapine D3  Chemical Structure
  46. GC17580 Olaparib (AZD2281, Ku-0059436)

    A PARP inhibitor

    Olaparib (AZD2281, Ku-0059436)  Chemical Structure
  47. GN10184 Oleanolic acid Oleanolic acid  Chemical Structure
  48. GC49815 Oleuropein aglycone A polyphenol with diverse biological activities Oleuropein aglycone  Chemical Structure
  49. GC13166 Omeprazole H+,K+-ATPase inhibitor Omeprazole  Chemical Structure
  50. GC36806 Omeprazole D3 Omeprazole D3 (H 16868-d3) is deuterium labeled Omeprazole. Omeprazole D3  Chemical Structure
  51. GC61155 Omeprazole sodium Omeprazole sodium (H 16868 sodium), a proton pump inhibitor (PPI), is available for treatment of acid-related gastrointestinal disorders. Omeprazole sodium  Chemical Structure
  52. GC64070 Omeprazole-d3-1 Omeprazole-d3-1  Chemical Structure
  53. GN10332 Onjisaponin B Onjisaponin B  Chemical Structure
  54. GC15778 ONX-0914 (PR-957) A selective inhibitor of the β5i (LMP7) subunit of the immunoproteasome ONX-0914 (PR-957)  Chemical Structure
  55. GC62210 ONX-0914 TFA ONX-0914 (PR-957) TFA is a selective inhibitor of low-molecular mass polypeptide-7 (LMP7), the chymotrypsin-like subunit of the immunoproteasome. ONX-0914 TFA  Chemical Structure
  56. GC15447 Oprozomib (ONX-0912) An orally available proteasome inhibitor Oprozomib (ONX-0912)  Chemical Structure
  57. GC39260 OR-1855 OR-1855, an active metabolite of Levosimendan, has effect on human myometrial contractility. OR-1855  Chemical Structure
  58. GN10732 Oroxin B Oroxin B  Chemical Structure
  59. GC41625 Oroxylin A

    Oroxylin A is a flavonoid that has been found in S.

    Oroxylin A  Chemical Structure
  60. GC14071 OSI-027 MTORC1/ mTORC2 inhibitor OSI-027  Chemical Structure
  61. GC15742 OSU-03012 (AR-12) Potent PDK1 inhibitor OSU-03012 (AR-12)  Chemical Structure
  62. GC36821 OSU-T315 OSU-T315 (ILK-IN-1) is a small Integrin-linked kinase (ILK) inhibitor with an IC50 of 0.6 μM, inhibiting PI3K/AKT signaling by dephosphorylation of AKT-Ser473 and other ILK targets (GSK-3β and myosin light chain). OSU-T315 abrogates AKT activation by impeding AKT localization in lipid rafts and triggers caspase-dependent apoptosis in an ILK-independent manner. OSU-T315 causes cell death through apoptosis and autophagy. OSU-T315  Chemical Structure
  63. GC10579 Ouabain Octahydrate

    selective Na+/K+-ATPase inhibitor

    Ouabain Octahydrate  Chemical Structure
  64. GC17716 Oxaliplatin Oxaliplatin is a cytotoxic chemotherapy drug used to treat cancer. Oxaliplatin  Chemical Structure
  65. GC30871 Oxidopamine hydrochloride (6-Hydroxydopamine hydrochloride) Oxidopamine (6-OHDA) hydrochloride is an antagonist of the neurotransmitter dopamine. Oxidopamine hydrochloride (6-Hydroxydopamine hydrochloride)  Chemical Structure
  66. GC33446 Oxyphenisatin acetate Oxyphenisatin acetate, the pro-drug of oxyphenisatin, is used to be a laxative. Oxyphenisatin acetate  Chemical Structure
  67. GC33464 Oxyresveratrol (trans-Oxyresveratrol) Oxyresveratrol (trans-Oxyresveratrol) (trans-Oxyresveratrol (trans-Oxyresveratrol)) is a potent naturally occurring antioxidant and free radical scavenger (IC50 of 28.9 μM against DPPH free radicals). Oxyresveratrol (trans-Oxyresveratrol)  Chemical Structure
  68. GC10379 P 22077 P 22077  Chemical Structure
  69. GC12067 P005091

    P005091 is a potent and selective ubiquitin-specific proteinase 7 (USP7) inhibitor with an EC50 value of 4.2 μM.

    P005091  Chemical Structure
  70. GC33008 p38 MAPK-IN-1 p38 MAPK-IN-1 (Compound 4) is a novel potent and selective inhibitor of p38 MAPK with IC50 of 68 nM. p38 MAPK-IN-1  Chemical Structure
  71. GC30609 p38 MAPK-IN-2 p38 MAPK-IN-2 is an inhibitor of p38 kinase. p38 MAPK-IN-2  Chemical Structure
  72. GC31988 p38α inhibitor 1 p38α inhibitor 1 is a p38α inhibitor extracted from patent WO 2008076265 A1. p38α inhibitor 1  Chemical Structure
  73. GC30158 p38-α MAPK-IN-1 p38-α MAPK-IN-1 is an inhibitor of MAPK14 (p38-α), with IC50 of 2300 nM in EFC displacement assay, and 5500 nM in HTRF assay. p38-α MAPK-IN-1  Chemical Structure
  74. GC38562 P62-mediated mitophagy inducer P62-mediated mitophagy inducer is a mitophagy regulator which activates mitophagy without recruiting Parkin or collapsing ΔΨm and retains activity in cells devoid of a fully functional PINK1/Parkin pathway. P62-mediated mitophagy inducer  Chemical Structure
  75. GC11993 PAC-1 An in vitro procaspase-3 activator PAC-1  Chemical Structure
  76. GC12511 Paclitaxel (Taxol)

    A potent mitotic inhibitor

    Paclitaxel (Taxol)  Chemical Structure
  77. GN10498 Paeonol Paeonol  Chemical Structure
  78. GC69650 Paeonol-d3

    Paeonol-d3 is deuterated Paeonol.

    Paeonol-d3  Chemical Structure
  79. GC14304 Palovarotene

    Selective retinoic acid receptor gamma(RAR-γ) agonist

    Palovarotene  Chemical Structure
  80. GC15814 Pamapimod (R-1503, Ro4402257) Pamapimod (R-1503, Ro4402257) (Ro4402257) is a potent, selective and orally active p38 MAPK inhibitor with IC50s of 14 nM and 480 nM and Kis of 1.3 nM and 120 nM for p38α and p38β, respectively. Pamapimod (R-1503, Ro4402257)  Chemical Structure
  81. GC12257 Panobinostat (LBH589) A pan-HDAC inhibitor Panobinostat (LBH589)  Chemical Structure
  82. GC12718 Pantoprazole H+/K+-ATPase inhibitor Pantoprazole  Chemical Structure
  83. GC36847 Pantoprazole sodium Pantoprazole sodium (BY10232 sodium) is an orally active and potent proton pump inhibitor (PPI). Pantoprazole sodium  Chemical Structure
  84. GC36848 Pantoprazole sodium hydrate Pantoprazole sodium hydrate (BY10232 sodium hydrate) is an orally active and potent proton pump inhibitor (PPI). Pantoprazole sodium hydrate  Chemical Structure
  85. GC36855 Paris saponin VII Paris saponin VII (Chonglou Saponin VII) is a steroidal saponin isolated from the roots and rhizomes of Trillium tschonoskii Maxim. Paris saponin VII-induced apoptosis in K562/ADR cells is associated with Akt/MAPK and the inhibition of P-gp. Paris saponin VII attenuates mitochondrial membrane potential, increases the expression of apoptosis-related proteins, such as Bax and cytochrome c, and decreases the protein expression levels of Bcl-2, caspase-9, caspase-3, PARP-1, and p-Akt. Paris saponin VII induces a robust autophagy in K562/ADR cells and provides a biochemical basis in the treatment of leukemia. Paris saponin VII  Chemical Structure
  86. GC17229 Paroxetine HCl Paroxetine HCl is a potent selective serotonin-reuptake inhibitor, commonly prescribed as an and has GRK2 inhibitory ability with IC50 of 14μM. Paroxetine HCl  Chemical Structure
  87. GC30992 Paroxetine hydrochloride hemihydrate (BRL29060 hydrochloride hemihydrate) Paroxetine hydrochloride hemihydrate (BRL29060 hydrochloride hemihydrate) is a potent selective serotonin-reuptake inhibitor, commonly prescribed as an antidepressant and has GRK2 inhibitory ability with IC50 of 14μM. Paroxetine hydrochloride hemihydrate (BRL29060 hydrochloride hemihydrate)  Chemical Structure
  88. GN10357 Parthenolide Parthenolide  Chemical Structure
  89. GC16327 Pazopanib (GW-786034) A multi-kinase inhibitor Pazopanib (GW-786034)  Chemical Structure
  90. GC12730 Pazopanib Hydrochloride VEGFR/PDGFR/FGFR/c-Kit/ c-Fms inhibitor Pazopanib Hydrochloride  Chemical Structure
  91. GC12205 PD 146176 PD 146176 is one of the potent and selective inhibitors of reticulocyte 15-LOX-1. PD 146176  Chemical Structure
  92. GC16912 PD 150606 An inhibitor of calpains PD 150606  Chemical Structure
  93. GC10561 PD 151746 calpain inhibitor, cell-permeable PD 151746  Chemical Structure
  94. GC17737 PD 169316 P38 MAPK inhibitor PD 169316  Chemical Structure
  95. GC19279 PD-166866 PD166866 is a selective FGFR1 tyrosine kinase inhibitor with an IC50 of 52.4 nM. PD-166866  Chemical Structure
  96. GC10397 PD0325901

    A MEK inhibitor that sustains stem cell renewal

    PD0325901  Chemical Structure
  97. GC11015 PD168393 EGFR inhibitor PD168393  Chemical Structure
  98. GC12819 PD98059

    PD98059 is a potent and selective MEK inhibitor with an IC50 of 2 μM.

    PD98059  Chemical Structure
  99. GN10084 Peiminine Peiminine  Chemical Structure
  100. GC11610 Pemetrexed An antifolate with anticancer activity Pemetrexed  Chemical Structure
  101. GC17694 Pemetrexed disodium hemipenta hydrate Pemetrexed disodium hemipenta hydrate  Chemical Structure

Items 701 to 800 of 1179 total

per page
  1. 6
  2. 7
  3. 8
  4. 9
  5. 10

Set Descending Direction